Fingerprint
Dive into the research topics of 'A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically